SCHEMBL6202494

SCHEMBL6202494

COc1cc(OC)c2c(c1)-c1[nH]c3ccc(O)cc3c1C2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
ROCK2 O75116 3/20 0.48
ELANE P08246 2/20 0.48
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
WEE1 P30291 8/20 0.44
CHEK1 O14757 7/20 0.44
CCNB2 O95067 2/20 0.44
CDK1 P06493 2/20 0.44
CCNB1 P14635 2/20 0.44
GSK3A P49840 2/20 0.44
GSK3B P49841 2/20 0.44
CDK5 Q00535 2/20 0.44
CDK5R1 Q15078 2/20 0.44
CCNB3 Q8WWL7 2/20 0.44
ABCG2 Q9UNQ0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7226290 0.99 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP3A4ROCK2ELANE
SCHEMBL6499254 0.90 ROCK2 (0.48) ALDH1A1CYP1A2CYP3A4ROCK2ELANE
SCHEMBL6203623 0.82 WEE1 (0.47) ROCK2CA1CA2CA4CA6
Hydrochloric Acid SCHEMBL7227282 0.81 WEE1 (0.46) ROCK2CA1CA2CA4CA6
SCHEMBL6506227 0.81 WEE1 (0.48) ALDH1A1ROCK2CA1CA2CA4
SCHEMBL6494988 0.80 MAOA (0.48) ALDH1A1CYP1A2CYP3A4CA1CA2
SCHEMBL6496944 0.78 WEE1 (0.46) ROCK2WEE1CHEK1
Hydrochloric Acid SCHEMBL7226753 0.75 ROCK2 (0.35) ROCK2CA1CA2CA4CA6
Hydrochloric Acid SCHEMBL7226757 0.75 ROCK2 (0.35) ROCK2CA1CA2CA4CA6
SCHEMBL6203750 0.73 ALDH1A1 (0.50) ALDH1A1ROCK2CCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1266887-B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2005-08-17 EP disclosed
US-6844445-B2 Indenoindolone compounds LES LABORATOIRES SERVIER (FR) 2005-01-18 US disclosed
EP-1245565-B1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-09-24 EP disclosed
EP-1266887-A2 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2002-12-18 EP disclosed
US-20020173531-A1 Indenoindolone compounds LES LABORATOIRES SERVIER (FR) 2002-11-21 US disclosed
EP-1245565-A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2002-10-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173531-A1 Indenoindolone compounds MTNR1A, MTNR1B, CYP11B1 ALDH1A1 232/4885CYP1A2 116/4885CYP3A4 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.